Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $63.71 million. The enterprise value is $42.10 million.
Important Dates
The last earnings date was Thursday, February 12, 2026, after market close.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.46 million shares outstanding. The number of shares has decreased by -0.20% in one year.
| Current Share Class | 16.46M |
| Shares Outstanding | 16.46M |
| Shares Change (YoY) | -0.20% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 17.70% |
| Owned by Institutions (%) | 28.23% |
| Float | 13.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.32 |
| Forward PS | 1.79 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | 191.89 |
| P/OCF Ratio | 120.66 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 126.80 |
Financial Position
The company has a current ratio of 9.72, with a Debt / Equity ratio of 0.01.
| Current Ratio | 9.72 |
| Quick Ratio | 5.96 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.42 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.85% and return on invested capital (ROIC) is -38.34%.
| Return on Equity (ROE) | -14.85% |
| Return on Assets (ROA) | -11.18% |
| Return on Invested Capital (ROIC) | -38.34% |
| Return on Capital Employed (ROCE) | -21.33% |
| Weighted Average Cost of Capital (WACC) | 11.29% |
| Revenue Per Employee | $458,033 |
| Profits Per Employee | -$128,650 |
| Employee Count | 60 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.06 |
Taxes
| Income Tax | -1.91M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.04% in the last 52 weeks. The beta is 1.29, so SRTS's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -19.04% |
| 50-Day Moving Average | 4.51 |
| 200-Day Moving Average | 4.09 |
| Relative Strength Index (RSI) | 39.99 |
| Average Volume (20 Days) | 69,342 |
Short Selling Information
The latest short interest is 483,655, so 2.94% of the outstanding shares have been sold short.
| Short Interest | 483,655 |
| Short Previous Month | 514,434 |
| Short % of Shares Out | 2.94% |
| Short % of Float | 3.57% |
| Short Ratio (days to cover) | 5.09 |
Income Statement
In the last 12 months, SRTS had revenue of $27.48 million and -$7.72 million in losses. Loss per share was -$0.47.
| Revenue | 27.48M |
| Gross Profit | 11.87M |
| Operating Income | -10.31M |
| Pretax Income | -9.62M |
| Net Income | -7.72M |
| EBITDA | -9.92M |
| EBIT | -10.31M |
| Loss Per Share | -$0.47 |
Full Income StatementBalance Sheet
The company has $22.08 million in cash and $471,000 in debt, with a net cash position of $21.61 million or $1.31 per share.
| Cash & Cash Equivalents | 22.08M |
| Total Debt | 471,000 |
| Net Cash | 21.61M |
| Net Cash Per Share | $1.31 |
| Equity (Book Value) | 48.10M |
| Book Value Per Share | 2.92 |
| Working Capital | 41.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $528,000 and capital expenditures -$196,000, giving a free cash flow of $332,000.
| Operating Cash Flow | 528,000 |
| Capital Expenditures | -196,000 |
| Depreciation & Amortization | 386,000 |
| Net Borrowing | n/a |
| Free Cash Flow | 332,000 |
| FCF Per Share | $0.02 |
Full Cash Flow StatementMargins
Gross margin is 43.18%, with operating and profit margins of -37.50% and -28.09%.
| Gross Margin | 43.18% |
| Operating Margin | -37.50% |
| Pretax Margin | -35.02% |
| Profit Margin | -28.09% |
| EBITDA Margin | -36.10% |
| EBIT Margin | -37.50% |
| FCF Margin | 1.21% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.20% |
| Shareholder Yield | 0.20% |
| Earnings Yield | -12.12% |
| FCF Yield | 0.52% |
Analyst Forecast
The average price target for SRTS is $6.67, which is 72.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.67 |
| Price Target Difference | 72.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTS has an Altman Z-Score of 9.97 and a Piotroski F-Score of 3.
| Altman Z-Score | 9.97 |
| Piotroski F-Score | 3 |
